Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 19Genitourinary 8Thoracic 6Lymphoid 6Gastrointestinal 6Gynecologic 5Tumor-Agnostic 3Other 3Dermatologic 3CNS 3Plasma cell 2Other hematologic neoplasm 2Sarcoma 1Head & Neck 1Endocrine 1

Conditions

Smoking Cessation 1Smoking 1Multiple Endocrine Neoplasia Type 1 1

Interventions

Everolimus 59lutetium Lu 177 dotatate 46Magnetic Resonance Spectroscopy 33pembrolizumab 31Temozolomide 31Cisplatin 29Nivolumab 26Octreotide 24lanreotide 23cabozantinib 22pasireotide 21gallium Ga 68 dotatate 21lenvatinib 20Etoposide 19Specimen Handling 18Paclitaxel 18Carboplatin 18Capecitabine 18Sunitinib 17Bevacizumab 16trametinib 15dabrafenib 15Doxorubicin 143-Iodobenzylguanidine 14surufatinib 13Sorafenib 13Ipilimumab 13Thyrotropin Alfa 12Injections 12Positron Emission Tomography Computed Tomography 11

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Cognitive Behavioral Therapy × Endocrine × Clear all
NCT02055326 2014-02-05

Yoga for Men Attempting Smoking Cessation

The Miriam Hospital

Phase NA Completed
38 enrolled
Endocrine

Smoking, Smoking Cessation, Multiple Endocrine Neoplasia Type 1

Data powered by HemOnc (CC BY 4.0) Colophon âš¡